Difference between revisions of "Team:NCTU Formosa/Composite Part"

Revision as of 02:48, 17 September 2015

Composite Parts

Composite Part


BBa_K1694013 OmpA-anti-VEGF BBa_K1694014 OmpA-anti-EGFR BBa_K1694015 OmpA-anti-HER2		In order to change the scFv parts easily, we added a NcoI restriction site between OmpA and scFv so that we can change various scFv DNA sequence using the NcoI restriction enzyme.
BBa_K1694023 Pcons+RBS+OmpA-anti-VEGF BBa_K1694024 Pcons+RBS+OmpA-anti-EGFR BBa_K1694025 Pcons+RBS+OmpA-anti-HER2		By ligating the constitutive promoter (BBa_J23101), strong ribosome binding site (BBa_B0034) and Lpp-OmpA-scFv, we were able to display scFv on the E. coli outer membrane continuously. Having this part, we can co-transform with other parts in order to produce color as the detection signal. In addition, by co-transforming these different types of E. coli with different fluorescence or color as signals, we are able to create a platform which can detect multimarker and consequently achieve combination therapy.
BBa_K1694033 Pcons+RBS+OmpA-anti-VEGF+RBS+GFP+Ter BBa_K1694034 Pcons+RBS+OmpA-anti-EGFR+RBS+GFP+Ter BBa_K1694035 Pcons+RBS+OmpA-anti-HER2+RBS+GFP+Ter BBa_K1694044 Pcons+RBS+OmpA-anti-EGFR+RBS+RFP+Ter BBa_K1694045 Pcons+RBS+OmpA-anti-HER2+RBS+BFP+Ter		The most commonly constructing way of composite parts is to ligate the required parts together. We also provide this kind of parts. At the back of the Lpp-OmpA-scFv part, we ligated the weaker ribosome biding site (BBa_B0030), different fluorescent protein and terminator (BBa_J61048) to make it continuously and simultaneously express the fluorescence and the scFv. We used a weak ribosome binding site to ensure that scFv's production will not be affected.
BBa_K1694053 Pcons+RBS+OmpA-anti-VEGF+RBS+amilCP+Ter BBa_K1694054 Pcons+RBS+OmpA-anti-EGFR+RBS+amilCP+Ter BBa_K1694055 Pcons+RBS+OmpA-anti-HER2+RBS+amilCP+Ter		Chromoprotein is another example of what can be added when making your own probe. We constructed this part as the Pcons+RBS+OmpA-scFv+RBS+fluorescent protein+Terminator part.
BBa_K1694027 Pinduce+RBS+FadL-GBP		By ligating the induced promoter (BBa_R0010), ribosome binding site (BBa_B0034), FadL-GBP and terminator (BBa_J61048), we can continuously display the GBP on the E. coli outer membrane. Then we co-transform the OmpA-scFv parts and this FadL-GBP parts into the same E. coli, hence allowing our E. coli to bind on gold chips and detect antigens simultaneously.
BBa_K1694037 Pinduce+RBS+FadL-GBP+RBS+GFP+Ter		With this part, we can testt the GBP function by observing the green fluorescence on the gold chip.

Reference
[1] C Hartmann et al. (2010) Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune responsehttp://www.nature.com/onc/journal/v29/n32/pdf/onc2010195a.pdf
[2] DrugBank: Bevacizumab (DB00112)http://www.drugbank.ca/drugs/DB00112
[3] DrugBank: Cetuximab (DB00002)http://www.drugbank.ca/drugs/DB00002
[4] DrugBank: Trastuzumab (DB00072)http://www.drugbank.ca/drugs/DB00072
[5] Tae Jung Park et al. (2009) Development of a whole-cell biosensor by cell surface display of a gold-binding polypeptide on the gold surfacehttp://www.ncbi.nlm.nih.gov/pubmed/19228193

Back to project

Go to Part Collection

Home
- Project
- Description
- Design
- Results
- Modeling
- Safety
- Notebook
- Lab Safety
- Lab Note
- Protocol
- Policy &
  Practices
- Human Practice
- Collaborations
Achievement
Team

NCTU_Formosa APOllO

National Chaio Tung University
Engineering Building 6 EF455, 1001 University Road, Hsinchu 300, Taiwan, ROC.

@@ Line 197: / Line 197: @@
                         <span><a href="http://parts.igem.org/Part:BBa_K1694025">BBa_K1694025</a></span><br>
                                  Pcons+RBS+OmpA-anti-HER2<br>
-</td><td></td><td>By ligating the constitutive promoter (<a href="http://parts.igem.org/Part:BBa_J23101">BBa_J23101</a>), strong ribosome binding site (<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a>) and Lpp-OmpA-scFv, we were able to display scFv on the <i>E.coli</i> outer membrane continuously.
+</td><td></td><td>By ligating the constitutive promoter (<a href="http://parts.igem.org/Part:BBa_J23101">BBa_J23101</a>), strong ribosome binding site (<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a>) and Lpp-OmpA-scFv, we were able to display scFv on the <i>E. coli</i> outer membrane continuously.
 Having this part, we can co-transform with other parts in order to produce color as the detection signal.<br><br>
-In addition, by co-transforming these different types of <i>E.coli</i> with different fluorescence or color as signals, we are able to create a platform which can detect <B>multimarker</B> and consequently achieve combination therapy.
+In addition, by co-transforming these different types of <i>E. coli</i> with different fluorescence or color as signals, we are able to create a platform which can detect <B>multimarker</B> and consequently achieve combination therapy.
 </td></tr>
@@ Line 230: / Line 230: @@
 <tr><td class="part"><span><a href="http://parts.igem.org/Part:BBa_K1694027">BBa_K1694027</a></span><br>
                                    Pinduce+RBS+FadL-GBP<br>
-</td><td></td><td>By ligating the induced promoter (<a href="http://parts.igem.org/Part:BBa_R0010">BBa_R0010</a>), ribosome binding site (<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a>), FadL-GBP and terminator (<a href="http://parts.igem.org/Part:BBa_J61048">BBa_J61048</a>), we can continuously display the GBP on the <i>E.coli</i> outer membrane.<br>
+</td><td></td><td>By ligating the induced promoter (<a href="http://parts.igem.org/Part:BBa_R0010">BBa_R0010</a>), ribosome binding site (<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a>), FadL-GBP and terminator (<a href="http://parts.igem.org/Part:BBa_J61048">BBa_J61048</a>), we can continuously display the GBP on the <i>E. coli</i> outer membrane.<br>
-Then we co-transform the OmpA-scFv parts and this FadL-GBP parts into the same <i>E.coli</i>, hence allowing our <i>E.coli</i> to bind on gold chips and detect antigens simultaneously.
+Then we co-transform the OmpA-scFv parts and this FadL-GBP parts into the same <i>E. coli</i>, hence allowing our <i>E. coli</i> to bind on gold chips and detect antigens simultaneously.
 </td></tr>